Age as a deciding factor in the consideration of futility for a medical intervention in patients among internal medicine physicians in two practice locations

Journal of the American Medical Directors Association
Dulce M Cruz-OliverMiguel A Paniagua

Abstract

This study explores physicians' concepts of futility and use of age as a deciding factor in considering medical futility in clinical interventions. Survey. Five academic hospitals in the United States. Participants were 355 internal medicine physicians, including 162 residents, 98 fellows, and 95 attending physicians. Anonymous questionnaire in which respondents were asked to define futility and to rate patient scenarios as futile or not, unaware that these were pairs of patient scenarios with similar clinical severity and treatment, but different age. Forty-five percent (n = 159) of physicians used the most accepted definition of futility in the literature: "a therapy that will not benefit the patient in attaining a specific goal." Physicians rated patient scenarios as futile for 58% of elder (> or =65 years) and for 59% of nonelder (<65 years) cases (P = .21). By training level, resident physicians rated more elder cases as futile (60%) than fellow/attending physicians (56%, P = .03). Rating of medical futility did not differ by practice location (59% in Missouri and 59% in Puerto Rico, P = .13). Physicians did not use age as a factor in deciding the futility of a medical intervention. In patient scenarios with comparable cli...Continue Reading

References

Dec 1, 1992·Critical Care Medicine·J E KassF Malakoff
Jun 15, 1990·Annals of Internal Medicine·L J SchneidermanA R Jonsen
Oct 1, 1985·Critical Care Medicine·W A KnausJ E Zimmerman
Apr 1, 1995·The Journal of Medicine and Philosophy·B A Brody, A Halevy
Nov 22, 1997·Journal of Clinical Epidemiology·D A AschN A Christakis
Feb 24, 2001·The New England Journal of Medicine·R L Fine, T W Mayo
May 15, 2002·Journal of Palliative Medicine·Robert A Burt
Oct 2, 2002·Journal of Palliative Medicine·Patricia B MullanCharles von Gunten
Apr 7, 2004·Mayo Clinic Proceedings·Paul S MuellerKevin C Fleming
Oct 16, 2004·Journal of General Internal Medicine·Deborah L Kasman
Nov 2, 2004·Intensive Care Medicine·Philippe Le ConteGille Potel
Jan 11, 2005·Clinics in Geriatric Medicine·Kathryn L MoseleySusan Dorr Goold
Jun 28, 2005·Academic Medicine : Journal of the Association of American Medical Colleges·Todd E GormanYoanna Skrobik
Feb 24, 2007·Wiener klinische Wochenschrift·Sophie Brunner-ZieglerAndreas Valentin
Jul 3, 2007·HEC Forum : an Interdisciplinary Journal on Hospitals' Ethical and Legal Issues·Griffin Trotter
Mar 13, 2008·Advances in Chronic Kidney Disease·Michael J Germain, Lewis M Cohen
Apr 1, 2009·Journal of Medical Ethics·R E Lawrence, F A Curlin

❮ Previous
Next ❯

Citations

Nov 5, 2016·Journal of Critical Care·Neza N SarkariAdit A Ginde
Jan 20, 2018·Journal of Advanced Nursing·Lauren Morata
May 17, 2021·Journal of the American Medical Directors Association·Sophie PutotAlain Putot

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.